Burkholderia Cepacia Infection
Also known as: Burkholderia cepacia complex infection
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00684 | Tobramycin | An aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00684 | Tobramycin | 16S ribosomal RNA | target |
| DB00684 | Tobramycin | Bacterial outer membrane | target |
| DB00684 | Tobramycin | Cytoplasmic membrane | target |
| DB00684 | Tobramycin | 23S ribosomal RNA | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17910 | SNSP113 | 1 | Terminated | 1 |
| DB00684 | Tobramycin | 1 | Completed | 1 |
| DB09050 | Ceftolozane | 4 | Not Yet Recruiting | 1 |
| DB01606 | Tazobactam | 4 | Not Yet Recruiting | 1 |